Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, TRI

YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024


SHANGHAI, March 13, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company pioneering in in vivo gene editing therapies, today announced participation in TIDES Asia 2024, March 19th to 21st, 2024, at the Westin Miyako Kyoto in Kyoto, Japan.

TIDES Asia, a conference in Asia that brings together discovery, clinical, delivery and CMC/manufacturing experts developing therapeutics/vaccines using modalities of Oligonucleotides, Peptides, mRNA and Genome Editing. Attendees from US, Europe and Asia come together to share scientific strategies and common challenges to help accelerate new molecules to market.

YolTech Therapeutics' representatives will bring latest advancements in in vivo gene editing technology and innovative LNP deliver system during the conference. Sincerely invites partners, investors, and stakeholders to join the session at TIDES Asia 2024 to share views of our breakthroughs.

Details are as follows:

Date: Wednesday, March 20, 2024
Time: 1:30pm -2:00pm JST
Location: The Westin Miyako Kyoto - Higashiyama Ward, Kyoto, Japan
Track: Track 1

About YolTech
YolTech Therapeutics is a pioneering gene editing company dedicated to develop a robust gene editing medicines to treat patients with serious diseases, which has built leading high-throughput evolution platform and innovative LNP deliver system. It possesses strong capability of novel Cas and base editor discovery and exceptional in-house LNP production capacity for GMP manufactory, with independent intellectual property rights and core patent protection globally. It has created a pipeline with 10+ genetic medicines focusing on cardiovascular diseases, metabolic diseases, infectious diseases as well as more common and rare diseases. Clinical trial clearance has been received for its leading in vivo gene editing asset YOLT-201 in March 2024.

For more information, please visit: www.yoltx.com or follow YolTech on LinkedIn https://www.linkedin.com/company/yoltech-therapeutics/

CONTACT: Wei Lu, [email protected]

SOURCE YolTech Therapeutics


These press releases may also interest you

at 08:50
Padraig McDonnell Assumes Agilent CEO Role
Agilent Technologies Inc. today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company's CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent's...

at 08:50
Oman Air Cargo Elevates Operations with RTS Cargo Suite: AI/ML Integration Boosts Revenue Management and Dynamic Pricing Strategies.
Oman Air Cargo, a prominent Middle Eastern airline renowned for its expansive global network spanning four continents, has embarked on a transformative strategic partnership with Revenue Technology Services (RTS) within the cargo division. This...

at 08:47
140 8th Graders In Socioeconomically-Disadvantaged Community Produce Animated TV Series Using In-School Education Tool Created By Former CEO Of The Company That Incubated The Simpsons And Rugrats
In the high desert community 72 miles outside Los Angeles, with public schools ranked at the bottom 50% of those in California, 140 8th grade students produced a 6-episode animated TV series, titled "Lancaster, California."  The students collaborated...

at 08:47
Body Boost Virtual Health Empowers Virginians to Take Charge of Their Health Through Virtual Care
Body Boost Virtual Health is revolutionizing the way Virginians access healthcare with their comprehensive range of telehealth services. The online provider offers convenient and affordable virtual consultations for individuals and families across...

at 08:47
Vision Films Set to Release Tech-Forward Family Fantasy "Princess Halle and The Jester"
Vision Films Inc. ("Vision") announces the North American Transactional VOD release of the groundbreaking fantasy Princess Halle and The Jester from writer, director and producer Christopher Lombardi on May 21, 2024. It will also have a day and date...

at 08:45
Paychex Declares a 10% Increase to Quarterly Cash Dividend
Paychex, Inc. , a leading provider of integrated human capital management software solutions for human resources, employee benefits, insurance services, and payroll, today announced that its Board of Directors approved a quarterly dividend of $0.98...

More news about Science and technology...


News published on and distributed by: